Page last updated: 2024-11-08

3,5-dichlorotyrosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-dichloro-L-tyrosine : A chloroamino acid that is L-tyrosine carrying chloro- substituents at positions C-3 and C-5 of the benzyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439986
CHEBI ID28016
SCHEMBL ID2122000
MeSH IDM0363500

Synonyms (27)

Synonym
nsc-210501
15106-62-4
C03347 ,
3,5-dichloro-l-tyrosine
3,5-dichlorotyrosine
dicly
CHEBI:28016 ,
SCHEMBL2122000
(s)-2-amino-3-(3,5-dichloro-4-hydroxyphenyl)propanoic acid
h-tyr(3,5-dicl)-oh
EPITOPE ID:122961
AKOS015891197
2lt ,
AM83556
h-tyr(3,5-cl2)-oh
J-300434
DTXSID40331461
l-tyrosine, 3,5-dichloro-
N303G0Z9AR ,
mfcd09842574
unii-n303g0z9ar
CS-W022756
DS-15892
Q27103454
A884115
HY-W042016
PD197164
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
chloroamino acidA haloamino acid that is an amino acid carrying at least one halogen atom.
dihalogenated L-tyrosineAn L-tyrosine derivative which has two halogeno-substituents on the benzyl moiety.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]